Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 1101 - 1200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1101 | 26733560 |
US |
||
Gait disturbance, Feeling abnormal, |
||||
LUMATEPERONE, |
||||
| 1102 | 26733934 |
US |
2 | |
Dialysis, Gait disturbance, |
||||
INSULIN GLARGINE, |
||||
| 1103 | 26734441 |
US |
68 | 2 |
Arthritis, Gait disturbance, Muscular weakness, Discomfort, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 1104 | 26734700 |
US |
70 | 1 |
Gait disturbance, Sleep disorder due to a general medical condition, Arthralgia, |
||||
DUPILUMAB, |
||||
| 1105 | 26735655 |
US |
84 | 1 |
Cerebrovascular accident, Visual impairment, Gait disturbance, Blindness, Nephrostomy, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, INSULIN ASPART, INSULIN GLARGINE, ATORVASTATIN CALCIUM, OLAPARIB, |
||||
| 1106 | 26735743 |
US |
2 | |
Peripheral swelling, Gait disturbance, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, AZELASTINE HYDROCHLORIDE, AZELASTINE, BUDESONIDE AND FORMOTEROL FUMARATE, CYANOCOBALAMIN, ERGOCALCIFEROL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FAMOTIDINE, FLUOXETINE HYDROCHLORIDE, MEDROXYPROGESTERONE ACETATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TIOTROPIUM BROMIDE, |
||||
| 1107 | 26740364 |
75 | 2 | |
Balance disorder, Migraine, Gait disturbance, Cerebrovascular accident, Malaise, Aphasia, Ataxia, Chronic kidney disease, |
||||
GABAPENTIN, |
||||
| 1108 | 26732908 |
US |
64 | 1 |
Legionella infection, Pneumonia, Gait disturbance, Weight decreased, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1109 | 26732939 |
78 | 2 | |
Dystonia, Malaise, Gait disturbance, Clumsiness, Discouragement, Back pain, Salivary hypersecretion, Somnolence, Dyskinesia, Dry mouth, Insomnia, |
||||
OPICAPONE, AMLODIPINE AND OLMESARTAN MEDOXOMIL, AAMLODIPINE AND OLMESARTAN MEDOXOMIL, ATENOLOL, |
||||
| 1110 | 26732950 |
EU |
65 | 2 |
Pericardial effusion, Asthenia, Gait disturbance, Pyrexia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, |
||||
| 1111 | 26733063 |
US |
62 | 2 |
Chest pain, Haemorrhage, Gait disturbance, Myocardial infarction, Troponin increased, Pollakiuria, Headache, Groin pain, Fatigue, Rheumatoid arthritis, Tinnitus, |
||||
UPADACITINIB, ETANERCEPT, EVOLOCUMAB, DUPILUMAB, BENRALIZUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 1112 | 26738504 |
2 | ||
Fall, Headache, Urinary tract infection, Intracranial mass, Disease progression, Jugular vein thrombosis, Cerebral venous sinus thrombosis, Asthenia, Chills, Ataxia, Dyspnoea, Nausea, Gait disturbance, |
||||
LOMUSTINE, |
||||
| 1113 | 26740318 |
81 | 2 | |
Adverse drug reaction, Bedridden, Influenza like illness, Visual impairment, Impaired driving ability, Sensory disturbance, Balance disorder, Gait disturbance, |
||||
AMOXICILLIN, |
||||
| 1114 | 26727924 |
TH |
84 | 1 |
Neuropathy peripheral, Gait disturbance, Vitamin B12 deficiency, Subdural haematoma, Fall, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LINAGLIPTIN, AMLODIPINE, VALSARTAN, VALSARTAN ORAL, SIMVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, PANTOPRAZOLE, |
||||
| 1115 | 26728109 |
EU |
1 | |
Brain stem syndrome, Neurological decompensation, Buccoglossal syndrome, Vomiting, Chills, Gait disturbance, Bradykinesia, Dysarthria, Dystonia, Mutism, Ataxia, Hypotension, Apnoeic attack, Stupor, |
||||
SEVOFLURANE, SEVOFLURANE, PROPOFOL, PROPOFOL, FENTANYL, FENTANYL, |
||||
| 1116 | 26728362 |
CA |
72 | 1 |
Death, Hypoxia, Pyrexia, Hospitalisation, Pneumonia, Cerebral haemorrhage, Choking, Vomiting, Tremor, Gait disturbance, Rash, Erythema, Pain in extremity, Peripheral swelling, Dental caries, Fatigue, Splenomegaly, Joint swelling, Mobility decreased, Dysphagia, Asthenia, Device dislocation, Wrong technique in product usage process, Product dose omission issue, Inappropriate schedule of product administration, |
||||
MOMELOTINIB, MOMELOTINIB, HYDROXYUREA, OXYGEN, 0XYGEN, |
||||
| 1117 | 26728648 |
BR |
41 | 2 |
Multiple sclerosis relapse, Pneumonia bacterial, Psoriasis, Genital herpes, Neoplasm, Hypoaesthesia, Gait disturbance, Trigeminal neuralgia, |
||||
OCRELIZUMAB, ALEMTUZUMAB, WARFARIN SODIUM, WARFARIN, METHYLPREDNISOLONE, |
||||
| 1118 | 26728649 |
US |
79 | 2 |
Freezing phenomenon, Feeling jittery, Gait disturbance, Dyspnoea, |
||||
PIMAVANSERIN TARTRATE, RANOLAZINE, RANOLAZINE, |
||||
| 1119 | 26728690 |
US |
87 | 2 |
Liver function test abnormal, Dehydration, Transient ischaemic attack, Pneumonia, Respiratory tract infection viral, Gait disturbance, Confusional state, Product dose omission issue, |
||||
ACALABRUTINIB, ACALABRUTINIB, |
||||
| 1120 | 26728789 |
US |
1 | |
Neuropathy peripheral, Pruritus, Hypoaesthesia, Depression, Psychiatric symptom, Gait disturbance, Condition aggravated, |
||||
DUPILUMAB, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 1121 | 26729035 |
US |
67 | 2 |
Gait disturbance, Pain, |
||||
SARILUMAB, |
||||
| 1122 | 26729311 |
US |
1 | |
Cardiac valve disease, Aphasia, Dizziness, Gait disturbance, |
||||
DIROXIMEL FUMARATE, |
||||
| 1123 | 26729774 |
US |
2 | |
Therapeutic response decreased, Gait disturbance, Dysstasia, |
||||
SARILUMAB, ALENDRONATE SODIUM, FOLIC ACID, HYALURONIC ACID, HYDROXYCHLOROQUINE SULFATE, LEUCOVORIN CALCIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, TIRZEPATIDE, PREDNISONE, SIMVASTATIN, |
||||
| 1124 | 26730373 |
2 | ||
Peripheral swelling, Pain in extremity, Gait disturbance, Palpitations, |
||||
RIBOCICLIB, |
||||
| 1125 | 26730432 |
2 | ||
Asthenia, Decreased appetite, Gait disturbance, |
||||
IMLUNESTRANT, |
||||
| 1126 | 26730574 |
US |
2 | |
Hypersensitivity, Gait disturbance, |
||||
OCRELIZUMAB, |
||||
| 1127 | 26730910 |
EU |
61 | 2 |
Nervous system disorder, Balance disorder, Headache, Dizziness, Dysstasia, Gait disturbance, Blood pressure increased, Impaired driving ability, Condition aggravated, Middle insomnia, Mobility decreased, |
||||
CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE, CANDESARTAN, |
||||
| 1128 | 26731178 |
CA |
71 | 2 |
Depressed level of consciousness, Gait disturbance, Dizziness, Injection site erythema, Headache, |
||||
TERIPARATIDE, BUPROPION, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 1129 | 26731273 |
US |
45 | 1 |
Foot fracture, Gait disturbance, Impaired driving ability, Fall, Oedema, |
||||
ELUXADOLINE, |
||||
| 1130 | 26731489 |
CA |
43 | 2 |
Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Depression, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Fatigue, Ear pain, Epilepsy, Exostosis, Facet joint syndrome, Feeling hot, Folliculitis, Fibromyalgia, Frequent bowel movements, Gait disturbance, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect route of product administration, Inflammation, Infusion related reaction, Infusion site reaction, Injection site reaction, Injury, Intentional product misuse, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Laboratory test abnormal, Laryngitis, Lip dry, Liver function test increased, Live birth, Liver disorder, Maternal exposure during pregnancy, Normal newborn, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, APREMILAST, APREMILAST, APREMILAST, CANDESARTAN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, ATOMOXETINE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, MEPOLIZUMAB, BUPRENORPHINE, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ACETAMINOPHEN AND CODEINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LANSOPRAZOLE, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 1131 | 26732281 |
GB |
13 | 1 |
Movement disorder, Dizziness, Inappropriate affect, Gait disturbance, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 1132 | 26732298 |
75 | 2 | |
Gait disturbance, Amaurosis, Hypoglycaemic unconsciousness, Hypoglycaemia, |
||||
INSULIN LISPRO, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1133 | 26732489 |
US |
||
Full blood count decreased, Neurotoxicity, Immune effector cell-associated haematotoxicity, Tremor, Gait disturbance, |
||||
BREXUCABTAGENE AUTOLEUCEL, |
||||
| 1134 | 26722762 |
US |
2 | |
Pain in extremity, Gait disturbance, |
||||
LEUPROLIDE ACETATE, |
||||
| 1135 | 26723131 |
CO |
42 | |
Nephrolithiasis, Abdominal distension, Gait disturbance, Back pain, |
||||
BUROSUMAB, BUROSUMAB, BUROSUMAB, BUROSUMAB, BUROSUMAB, BUROSUMAB, BUROSUMAB, BUROSUMAB, BUROSUMAB, BUROSUMAB, |
||||
| 1136 | 26723202 |
US |
79 | 2 |
Muscle spasms, Nausea, Gait disturbance, Dizziness, Nasopharyngitis, Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 1137 | 26723272 |
US |
63 | 2 |
Tremor, Gait disturbance, |
||||
LORAZEPAM, HYDROXYZINE, SPIRONOLACTONE, FLUOXETINE HYDROCHLORIDE, |
||||
| 1138 | 26723501 |
EC |
65 | 2 |
Gait disturbance, Pain in extremity, Hypersensitivity, |
||||
INTERFERON BETA-1A, |
||||
| 1139 | 26723563 |
KE |
||
Mobility decreased, Gait disturbance, Muscular weakness, Exercise tolerance decreased, Muscle atrophy, General physical health deterioration, |
||||
| 1140 | 26724007 |
EU |
8 | 1 |
Depressed level of consciousness, Hypersomnia, Bradykinesia, Gait disturbance, Vomiting, Stupor, Hiccups, |
||||
SEVOFLURANE, |
||||
| 1141 | 26724022 |
JP |
79 | 2 |
Cerebral infarction, Diplopia, Dyslalia, Gait disturbance, |
||||
ONABOTULINUMTOXINA, |
||||
| 1142 | 26724127 |
US |
2 | |
Arthralgia, Platelet count decreased, Blood calcium decreased, Pelvic pain, Gait disturbance, |
||||
LENALIDOMIDE, |
||||
| 1143 | 26724187 |
67 | ||
Road traffic accident, Gait disturbance, |
||||
BRIVARACETAM, |
||||
| 1144 | 26724636 |
US |
82 | |
Gait disturbance, |
||||
ISTRADEFYLLINE, |
||||
| 1145 | 26724709 |
EU |
65 | 1 |
Euthanasia, Anxiety, General physical health deterioration, Mental impairment, Hallucination, Gait disturbance, Fall, Balance disorder, Dyskinesia, Restlessness, Disease risk factor, Loss of personal independence in daily activities, Osteoarthritis, On and off phenomenon, |
||||
MAGNESIUM OXIDE, CLOZAPINE, |
||||
| 1146 | 26724931 |
US |
55 | 2 |
Dermatitis atopic, Pruritus, Headache, Myalgia, Gait disturbance, Sleep disorder due to a general medical condition, Tendon pain, Loss of personal independence in daily activities, |
||||
DUPILUMAB, PREDNISONE, |
||||
| 1147 | 26725283 |
US |
77 | 2 |
Wrong technique in product usage process, Myalgia, Movement disorder, Gait disturbance, Injury, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1148 | 26725289 |
51 | ||
Foot operation, Mental disorder, Procedural pain, Gait disturbance, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DIPHENHYDRAMINE HYDROCHLORIDE, CELECOXIB, CETIRIZINE HCL, CETIRIZINE, FLUTICASONE PROPIONATE, GABAPENTIN, LOSARTAN POTASSIUM, LOSARTAN, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RIZATRIPTAN, GUSELKUMAB, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, FAMOTIDINE, |
||||
| 1149 | 26725359 |
US |
20 | 2 |
Fall, Gait disturbance, Speech disorder, |
||||
OMAVELOXOLONE, |
||||
| 1150 | 26725448 |
US |
84 | 2 |
Paralysis, Mental disorder, Cognitive disorder, Sleep disorder, Gait disturbance, Incontinence, Parkinsonism, Aphasia, Tardive dyskinesia, Depressed level of consciousness, Adverse drug reaction, Mental impairment, |
||||
GABAPENTIN, ARIPIPRAZOLE, ARIPIPRAZOLE, VILAZODONE HYDROCHLORIDE, CLONAZEPAM, |
||||
| 1151 | 26725450 |
US |
||
Pneumonia, Gait disturbance, |
||||
OCRELIZUMAB, |
||||
| 1152 | 26725571 |
US |
||
Haemoptysis, Agitation, Rhinorrhoea, Hunger, Back pain, Migraine, Dyspnoea, Chest discomfort, Brain fog, Gait disturbance, Eructation, Reflux gastritis, Abdominal pain, Insomnia, Fatigue, Cough, Anxiety, Chills, Pain, Nausea, Gastrointestinal disorder, Cold sweat, Weight decreased, Flatulence, Depression, Pulmonary function test decreased, Nightmare, Diarrhoea, Headache, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, DORNASE ALFA, PANCRELIPASE, |
||||
| 1153 | 26725596 |
EU |
80 | 1 |
Akinesia, Parkinson^s disease, Sleep disorder, Somnolence, Cough, Unevaluable event, Perseveration, Anal incontinence, Gait disturbance, Disorientation, Drug ineffective, Treatment noncompliance, Incorrect dose administered, Wrong technique in device usage process, Product residue present, |
||||
LEVODOPA, LEVODOPA, CARBIDOPA AND LEVODOPA, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CYANOCOBALAMIN, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 1154 | 26725762 |
US |
46 | 2 |
Lower respiratory tract infection, Feeling hot, Gait disturbance, Headache, Pain, Abdominal pain, Nausea, Visual impairment, Dyspnoea, Vomiting, Eye pain, Urinary tract infection, Influenza like illness, Chills, Pyrexia, Feeding disorder, Migraine, Delusion, Fatigue, Asthenia, White blood cell count increased, Rash, Pruritus, Feeling hot, Feeling abnormal, |
||||
OFATUMUMAB, OFATUMUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1155 | 26725810 |
US |
21 | 2 |
Acute hepatic failure, Suicidal ideation, Aggression, Memory impairment, Gait disturbance, Encephalopathy, Acute kidney injury, Contraindicated product administered, Generalised tonic-clonic seizure, Hepatorenal syndrome, Condition aggravated, Grip strength decreased, Renal tubular necrosis, Drug ineffective, Homicidal ideation, Drug-induced liver injury, Multiple organ dysfunction syndrome, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, PREGABALIN, LACOSAMIDE, VALPROIC ACID, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, PERAMPANEL, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, BASILIXIMAB, PREDNISONE, PREDNISONE, |
||||
| 1156 | 26726399 |
CA |
2 | |
Thrombosis, Gait disturbance, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, |
||||
| 1157 | 26727216 |
13 | ||
Adverse drug reaction, Petit mal epilepsy, Agitation, Anxiety, Dizziness, Asthenia, Gait disturbance, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 1158 | 26727255 |
US |
61 | 2 |
Extra dose administered, Fatigue, Confusional state, Thinking abnormal, Gait disturbance, Somnolence, Dysarthria, Pain, |
||||
TIRZEPATIDE, |
||||
| 1159 | 26727821 |
EU |
12 | 1 |
Respiratory failure, Stupor, Depressed level of consciousness, Hypersomnia, Sepsis, Neurological decompensation, Dystonia, Gait disturbance, Ataxia, Dysphagia, Mutism, |
||||
SEVOFLURANE, |
||||
| 1160 | 26717903 |
US |
1 | |
Laboratory test abnormal, Night sweats, Chills, Muscular weakness, Decreased appetite, Headache, Asthenia, Brain fog, Tremor, Gait disturbance, Haemoglobin decreased, Haematocrit decreased, Platelet count decreased, Blood immunoglobulin A decreased, Blood immunoglobulin G decreased, Blood immunoglobulin M increased, Weight decreased, Blood iron abnormal, |
||||
ZANUBRUTINIB, ZANUBRUTINIB, |
||||
| 1161 | 26717918 |
US |
1 | |
Speech disorder, Gait disturbance, Post procedural complication, Single functional kidney, General physical health deterioration, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 1162 | 26717940 |
US |
67 | 2 |
Gait disturbance, Myalgia, Myositis, Muscle swelling, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1163 | 26718196 |
US |
2 | |
Joint swelling, Gait disturbance, Off label use, Arthralgia, Injection site erythema, Injection site pain, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 1164 | 26718229 |
US |
2 | |
Hepatic cirrhosis, Gait disturbance, Intentional product misuse, |
||||
APREMILAST, |
||||
| 1165 | 26718554 |
US |
17 | 1 |
Sedation complication, Treatment noncompliance, Off label use, Gait disturbance, |
||||
LORAZEPAM, LORAZEPAM, AMANTADINE, |
||||
| 1166 | 26718597 |
US |
2 | |
Urinary tract infection, Gait disturbance, Vertigo, Visual impairment, |
||||
ATOGEPANT, |
||||
| 1167 | 26719031 |
US |
50 | 2 |
Rheumatoid arthritis, Gait disturbance, Discomfort, Meniscus injury, Arthralgia, |
||||
DUPILUMAB, |
||||
| 1168 | 26719111 |
US |
67 | 1 |
Balance disorder, Impaired healing, Peripheral swelling, Erythema, Decreased appetite, Injection site pain, Gait disturbance, Sensitive skin, Feeling abnormal, Dizziness, White blood cell count decreased, Herpes zoster, Upper respiratory tract infection, Injection site erythema, |
||||
SARILUMAB, CLONIDINE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, PREDNISONE, EVOLOCUMAB, |
||||
| 1169 | 26720047 |
US |
2 | |
Drug ineffective, Gait disturbance, |
||||
TOCILIZUMAB, |
||||
| 1170 | 26720099 |
US |
78 | 2 |
Dry eye, Vision blurred, Gait disturbance, Arthralgia, Balance disorder, Paraesthesia, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1171 | 26720162 |
US |
2 | |
Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1172 | 26720415 |
ZA |
1 | |
Haemoglobin decreased, Platelet count increased, Blood creatinine increased, C-reactive protein increased, Rheumatoid arthritis, Gait disturbance, Hip fracture, Product dose omission issue, Arthralgia, Ankle fracture, |
||||
RITUXIMAB, |
||||
| 1173 | 26720721 |
CA |
71 | 1 |
Fall, Arthralgia, Mobility decreased, Balance disorder, Muscular weakness, Gait disturbance, |
||||
OCRELIZUMAB, |
||||
| 1174 | 26720946 |
CA |
57 | 2 |
Multiple sclerosis, Balance disorder, Tremor, Pruritus, Throat irritation, Hypertension, Confusional state, Tooth fracture, Temperature intolerance, Osteitis, Burning sensation, Fatigue, Stress, Muscular weakness, Dental caries, Vitamin D decreased, Dry skin, Headache, Feeling abnormal, Drug ineffective, Infusion related reaction, Infection, Arthralgia, Head discomfort, Eye pain, Sensory loss, Feeling cold, Decreased activity, Asthenia, Gait disturbance, Neck pain, |
||||
PANTOPRAZOLE, OCRELIZUMAB, BACLOFEN, CARBAMAZEPINE, MIRABEGRON, DALFAMPRIDINE, |
||||
| 1175 | 26721087 |
CO |
79 | 1 |
Myocardial infarction, Infarction, Cardiac operation, Hyperhidrosis, Fatigue, Product dose omission issue, Gait disturbance, Prostatitis, Memory impairment, |
||||
APALUTAMIDE, APALUTAMIDE, |
||||
| 1176 | 26721092 |
US |
66 | 2 |
Hypertension, Headache, Nausea, Rash erythematous, Hyperkeratosis, Gait disturbance, Blister, Dry mouth, Stomatitis, |
||||
LENVATINIB, LENVATINIB, |
||||
| 1177 | 26721208 |
US |
42 | 2 |
Intestinal perforation, Liver function test abnormal, Spinal osteoarthritis, Facet joint syndrome, Osteoarthritis, Greater trochanteric pain syndrome, Gait disturbance, Injection site erythema, Photosensitivity reaction, Dry mouth, Dry skin, Device malfunction, Disease complication, Chills, Pyrexia, Weight increased, Weight decreased, Rash, Skin lesion, Back pain, Arthralgia, Joint stiffness, Joint swelling, Muscular weakness, Myalgia, Neck pain, Contusion, Lymphadenopathy, Injection site discolouration, |
||||
ASFOTASE ALFA, ASFOTASE ALFA, |
||||
| 1178 | 26721291 |
US |
34 | 1 |
Idiopathic intracranial hypertension, Gait disturbance, |
||||
ESTROGENS, CONJUGATED, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
| 1179 | 26721378 |
BR |
42 | 1 |
Bursitis, Gait disturbance, Dysmetria, Mobility support, Postoperative wound infection, Impaired healing, |
||||
OCRELIZUMAB, |
||||
| 1180 | 26721487 |
US |
68 | 2 |
Visual acuity reduced, Gait disturbance, Memory impairment, Agraphia, Anxiety, |
||||
NATALIZUMAB, |
||||
| 1181 | 26721555 |
US |
||
Hepatic function abnormal, Amnesia, Personality change, Gait disturbance, Unevaluable event, |
||||
GIVOSIRAN SODIUM, |
||||
| 1182 | 26721748 |
US |
61 | 2 |
Fall, Injury, Gait disturbance, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1183 | 26721784 |
EU |
79 | 1 |
Stoma site reaction, Dyskinesia, Lung disorder, Balance disorder, Pneumonia aspiration, Musculoskeletal stiffness, Stoma site hypergranulation, Dyspnoea, Mobility decreased, Sleep terror, Bradykinesia, Stoma site discharge, Device occlusion, Speech disorder, Gait disturbance, Fall, Spinal deformity, Device issue, Stoma site erythema, On and off phenomenon, Therapeutic product effect incomplete, Dysphonia, Hallucination, visual, |
||||
AMANTADINE, CARBIDOPA AND LEVODOPA, RASAGILINE MESYLATE, |
||||
| 1184 | 26721815 |
US |
2 | |
Cerebrovascular accident, Sluggishness, Mood swings, Fatigue, Insomnia, Vomiting, Gait disturbance, Paraesthesia, |
||||
BELIMUMAB, |
||||
| 1185 | 26721917 |
15 | ||
Epilepsy, Pyrexia, Gait disturbance, |
||||
FENFLURAMINE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, PERAMPANEL, PERAMPANEL, VALPROATE SODIUM, CLONAZEPAM, |
||||
| 1186 | 26722219 |
US |
31 | |
Pulmonary oedema, Failure to thrive, Abnormal behaviour, Fall, Mobility decreased, Influenza like illness, Body temperature abnormal, Hyperhidrosis, Product dose omission issue, Inappropriate schedule of product administration, Adverse event, Gait disturbance, Tremor, Weight decreased, Decreased appetite, |
||||
CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, OXCARBAZEPINE, DIVALPROEX SODIUM, |
||||
| 1187 | 26722271 |
2 | ||
Gait disturbance, Contusion, Dysstasia, Lymphoedema, Blood test abnormal, Undersensing, Contusion, Hyperventilation, Urticaria, Burning sensation, Burning sensation, Loss of consciousness, Peripheral swelling, Peripheral swelling, Diarrhoea, Dizziness, Peripheral swelling, Pain in extremity, Pruritus, Circulatory collapse, Drug hypersensitivity, Dyspnoea, Maternal exposure during pregnancy, Hypersensitivity, |
||||
IRON SUCROSE, IRON SUCROSE, IRON SUCROSE, IRON SUCROSE, IRON SUCROSE, IRON SUCROSE, |
||||
| 1188 | 26722395 |
US |
2 | |
Fall, Tremor, Gait disturbance, Dizziness, |
||||
VALBENAZINE, |
||||
| 1189 | 26722702 |
US |
61 | 2 |
Pleural effusion, Bone disorder, Somnolence, Flatulence, Muscle spasms, Blood potassium decreased, Foot deformity, Gait disturbance, Productive cough, Swelling, Incontinence, Nerve injury, Carbohydrate antigen 27.29 increased, Stress, Tooth fracture, Vomiting, Diarrhoea, Anaemia, White blood cell count decreased, Dry throat, Therapy non-responder, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, FUROSEMIDE, FULVESTRANT, |
||||
| 1190 | 26722723 |
JP |
||
Condition aggravated, Pyoderma, Gait disturbance, |
||||
ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, |
||||
| 1191 | 26724840 |
59 | 1 | |
Blister, Gait disturbance, |
||||
CABOZANTINIB, |
||||
| 1192 | 26711602 |
EU |
79 | 1 |
Hip fracture, Hyperresponsive to stimuli, On and off phenomenon, Cognitive disorder, Posture abnormal, Speech disorder, Muscle rigidity, Dyskinesia, Loss of personal independence in daily activities, Restlessness, Tension, Mobility decreased, Depressed level of consciousness, Disease risk factor, Middle insomnia, Aggression, Constipation, Gait disturbance, Hallucination, Emotional distress, Weight decreased, Hypophagia, Anal incontinence, General physical health deterioration, Wound, Gait inability, Enteral nutrition, Unevaluable event, Hyperkinesia, Agitation, Unevaluable event, Movement disorder, Motor dysfunction, Unevaluable event, Fall, |
||||
RIVASTIGMINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, QUETIAPINE, FINASTERIDE, |
||||
| 1193 | 26711624 |
CO |
64 | 2 |
Gait disturbance, Bedridden, |
||||
DURVALUMAB, |
||||
| 1194 | 26711826 |
US |
1 | |
Drooling, Asthenia, Somnolence, Confusional state, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 1195 | 26711996 |
EU |
19 | 1 |
Diarrhoea, Nausea, Skin exfoliation, Pancytopenia, Muscle atrophy, Cachexia, Haematochezia, Skin discolouration, Renal failure, Gait disturbance, Graft versus host disease, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CYCLOSPORINE, CYCLOSPORINE, RUXOLITINIB, RUXOLITINIB, LETERMOVIR, LETERMOVIR, |
||||
| 1196 | 26712004 |
EG |
45 | 2 |
Tachycardia, Lip swelling, Dyspnoea, Generalised oedema, Hypoaesthesia, Oropharyngeal pain, Gait disturbance, Chills, Fatigue, Hypotension, Anaphylactic shock, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ONDANSETRON HYDROCHLORIDE, |
||||
| 1197 | 26712277 |
US |
2 | |
Inappropriate schedule of product administration, Limb discomfort, Gait disturbance, |
||||
TENAPANOR HYDROCHLORIDE, |
||||
| 1198 | 26712330 |
EG |
37 | 2 |
Multiple sclerosis, Limb discomfort, Pain, Gait disturbance, Sleep disorder, |
||||
OCRELIZUMAB, |
||||
| 1199 | 26712376 |
US |
53 | |
Seizure, Fall, Injury, Pelvic fracture, Shoulder fracture, Spinal fracture, Loss of consciousness, Hip fracture, Fall, Seizure cluster, Influenza, Hypersensitivity, Urinary tract infection, Seizure, Infection, Wrong technique in product usage process, Feeling abnormal, Product dose omission issue, Repetitive speech, Insomnia, Stress, Product dose omission issue, Knee deformity, Seizure, Abdominal pain upper, Tremor, Malaise, Gait disturbance, Malaise, |
||||
CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LACOSAMIDE, ZONISAMIDE, ZONISAMIDE, ZONISAMIDE, LORAZEPAM, LORAZEPAM, OXYCODONE, |
||||
| 1200 | 26712424 |
US |
||
Gait disturbance, Arthralgia, |
||||
BOSENTAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30